11285 Stories, most recent news story added 2 hours 57 minutes ago
MONDAY, Dec. 14 (HealthDay News) -- Here's good news for people who can't start their morning without a cup or two of java: Coffee and tea consumption may decrease the risk of developing type 2 diabetes.
People who drink the most coffee and tea, even decaffeinated versions, can dramatically lower their risk of diabetes, researchers reported on Monday.
Dec. 14 (Bloomberg) -- Coffee can now add a lower risk of Type 2 diabetes to a resume of health benefits that grew last week when researchers found the wake-up drink helped against the deadliest form of prostate cancer.
Dec. 14 (Bloomberg) -- Drinking four cups of coffee, decaf or tea daily can reduce the risk of getting Type 2 diabetes by about 25 percent to 35 percent, said a review of research.
Dec. 15 (Bloomberg) -- Takeda Pharmaceutical Co. and Pfizer Inc. will jointly promote Takeda’s Actos diabetes drug in China. The companies said in a press release today that China may become the third-largest drug market by 2011.
Drinking more coffee (regular or decaffeinated) or tea appears to lower the risk of developing type 2 diabetes, according to a new analysis.
Every cup of coffee a person drinks per day may lower the risk of diabetes by 7%.
The chance discovery of a genetic mutation that makes mice enormously fat but protects them from diabetes has given researchers at Boston University School of Medicine, USA, new insights into the cellular mechanisms that link obesity to type 2 diabetes. Dr Gerald Denis and his colleagues report their findings in the current issue of The Biochemical Journal.
An overwhelming majority of people who have periodontal (gum) disease are also at high risk for diabetes and should be screened for diabetes, a New York University nursing-dental research team has found.
Individuals who drink more coffee (regular or decaffeinated) or tea appear to have a lower risk of developing type 2 diabetes, according to an analysis of previous studies reported in the December 14/28 issue of Archives of Internal Medicine.
Injecting the corticosteroid triamcinolone into the eye may slow the progression of diabetic retinopathy, a complication of diabetes that can cause vision loss and blindness, according to a report in the December issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
